LPA and metabolic syndrome: The potentially damaging variants in the LPA, PDIA2, APOBEC1, BRCA2, PCCB, AGPAT2, CREBBP, and MYL5 genes are in each case fairly evenly distributed between the four different dyslipidemia subphenotypes.